Vasopressor Therapy.

In the randomized controlled VANISH trial [ 13 ], vasopressin administration was associated with a somewhat lower incidence of renal failure, including less need for renal replacement therapy (RRT), but the differences did not reach statistical significance.

also in 111,027 other papers